An efficient method has been developed for the synthesis of 2-amino-4-(4-fluoro-3-(2-fluoropyridin-3-yl)phenyl)-4-(4-methoxy-3-methylphenyl)-1-methyl-1H-imidazol-5(4H)-one, a potent BACE1 inhibitor for the potential treatment of Alzheimer's Disease. The new method features a Friedel-Crafts reaction between 3-bromo-4-fluorophenylacetic acid and 2-methoxytoluene followed by DMSO mediated α-oxidation of the resulting 1,2-diarylethanone to give an α-diketone. Subsequent aminohydantoin formation and Suzuki coupling led to the target molecule in greater than 70% overall yield.
Introduction
Alzheimer's Disease (AD) is a neurodegenerative disease that leads to progressive decline in cognitive function and ultimately incapacitation and death. [1] [2] [3] [4] The amyloid cascade is a leading hypothesis for the cause of AD. According to this hypothesis, processing of the amyloid precursor protein (APP) by β-secretase (β-site APP Cleaving Enzyme or BACE1) followed by γ-secretase releases the putative Aβ peptide, which has been implicated in the neurodegeneration associated with the disease. BACE1 is a type I membrane associated aspartyl protease and is rate-limiting in this proteolytic process. Based on the key role of BACE1 in the β-amyloid cascade, inhibition of BACE1 is considered a prominent therapeutic target for treating AD. [5] [6] [7] [8] In this regard, we recently reported that 2-amino-4-(4-fluoro-3-(2-fluoropyridin-3-yl)phenyl)-4-(4-methoxy-3-methylphenyl)-1-methyl-1H-imidazol-5(4H)-one 1 was a potent BACE1 inhibitor (BACE1 IC 50 40 nM).
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Compound 1 was originally prepared in seven transformations from commercially available 2-bromo-1-fluoro-4-methylbenzene and 4-methoxy-3-methylbenzoic acid.
9 While this original method was successfully used to prepare enough of the desired final product 1 for initial biological tests, the low overall yield and multiple tedious purifications made this route inefficient for large scale synthesis to support further in vivo evaluation. In this report, we describe a new and efficient synthesis of the target compound using readily commercially available 3-bromo-4-fluorophenylacetic acid 2 and 2-methoxytoluene 3 as starting materials (Scheme 1) Thus, Friedel-Crafts reaction of 2 with 2-methoxytoluene 3 in PPA gave the corresponding ketone 4 in 82% yield. 10 With a large quantity of 5 in hand, we began to optimize the aminohydantoin formation and Suzuki coupling step. We found that the formation of aminohydantoin 6 could be best carried out by treating 5 and methylguanidine in a mixture of dioxane and ethanol at 70 o C for 5 hr, instead of refluxing overnight, the conditions initially employed. 12 In this way, compound 6 was isolated in 99% yield. For the subsequent Suzuki coupling of 6 with boronic acid 7, we found Pd(PPh 3 ) 2 Cl 2 /PPh 3 is superior to the more commonly used Pd(PPh 3 ) 4, and provided 1 in 90% yield. 13 In summary, a new and efficient method has been developed for the synthesis of 2-amino-4-(4-fluoro-3-(2-fluoropyridin-3-yl)phenyl)-4-(4-methoxy-3-methylphenyl)-1-methyl-1H-imidazol-5(4H)-one, a potent BACE1 inhibitor for the potential treatment of Alzheimer's disease. The new method features a Friedel-Crafts reaction between 3-bromo-4-fluorophenylacetic acid and 2-methoxytoluene, followed by DMSO mediated α-oxidation of the resulting 1,2-diarylethanone to give key α-diketone intermediate 5. Subsequent aminohydantoin formation and Suzuki coupling led to the target molecule in 71% overall yield. This new synthesis not only avoids multiple time consuming chromatographic separations, but also shortens the reaction sequence from seven to four steps. Furthermore, the overall yield was greatly improved from a variable 10-26% to 71% with less expensive starting materials employed. In addition we expect that the new two step method that was developed for the rapid large scale synthesis of 1,2-diketones will find broad applications in organic and medicinal chemistry due to the versatility of these building blocks. The preparation of a variety of synthetically and/or biologically important compounds such as imidazoles, 14 2-thioxoimidazolidin-4-one and imidazolidine-2,4-diones, 15 quinoxalines, 16 and 1,2,3,4-tetrahydroquinoxalines can be effected from these key intermediates. cooled to room temperature. To the resulting deep red solution was added ice-water (300 mL) slowly to decompose the excess polyphosphoric acid. A gummy solid was formed. The aqueous solution was decanted and the resulting gummy solid was dissolved in EtOAc (600 mL). The organic solution was washed with 1N aqueous NaOH (2x200 mL), H 2 O (200 mL), brine (200 mL), dried (MgSO 4 ) and concentrated to give a wet solid, which was triturated with hexane (300 mL) to give a solid. The solid was collected by filtration, washed with hexane (100 mL), airdried to give the first crop product (64.3 g, 76%). The mother liquid was concentrated and triturated with hexane to give the second crop product (4.5 g, 5%, total yield 81%). 1-(3-bromo-4-fluorophenyl)-2-(3-methoxy-4-methylphenyl) -4-(3-bromo-4-fluorophenyl)-4-(4-methoxy-3-methylphenyl)-1-methyl-1H-imidazol-5(4H)-one 6 . To a stirred solution of 1-(3-bromo-4-fluorophenyl)-2-(3-methoxy-4-methylphenyl)ethane-1,2-dione (5, 46.7 g, 133 mmol) and N-methylguanidine hydrochloride (24.2 g, 221 mmol) in EtOH (500 mL), dioxane (500 mL) and H 2 O (100 mL) was added Na 2 CO 3 (39.0 g, 368 mmol) in one portion at room temperature. After heating the reaction at 70 o C for 5h, the reaction mixture was cooled and concentrated. 2 mmol) and Na 2 CO 3 (17.8 g, 167.9 mmol) at room temperature. The reaction mixture was refluxed for 3.5 h, cooled and concentrated. The residue was dissolved in EtOAc and filtered through a plug of silica gel with EtOAc. The filtrate was concentrated to a small volume when it was treated with HCl (240 mL, 1N, in Et 2 O) solution. The mixture was triturated with Et 2 O and the solid was collected by filtration. The solid was dissolved in EtOH and adjusted pH to ~12 with sat. Na 2 CO 3 and extracted with EtOAc. The combined organic extracts were washed with brine, dried (MgSO 4 ) and concentrated. The crude product was purified by a short column (silica gel, EtOAc/hexane: 50-100%/50-0%, 2.0M NH 3 in EtOH/EtOAc: 10/90) to afford the titled compound (30. 
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